Skip to main content
Skip to navigation
Vaccine and Infectious Disease Organization
Menu
Search the USask
Search
About
About
History
Mission, Vision, Values
Safety & Security
Facilities
Community Liaison Committee
Frequently Asked Questions
Contact Us
Annual Reports
Donor Information
Team
Board of Directors
Senior Leadership
Science Management
Principal Scientists and Veterinarians
Contract Research
Scientific Advisory Board
Access Committee
Research
Research Projects
Veterinary Services
Publications
Patents
One Health
Contract Services
All Contract Services
Contract Development and Manufacturing
Contract Research
Careers
Current Opportunities
Working at VIDO
Benefits at VIDO
Training
Visiting Scientists
News
Donate Now
Index
News Archive - 2020
VIDO’s COVID-19 vaccine receives Health Canada clinical trial approval
VIDO-InterVac approved to work on SARS-CoV-2
USask VIDO-InterVac expands international role to test antiviral compounds against COVID-19
New CT scanner gives USask’s VIDO-InterVac scientists a window on COVID-19 disease
Increasing Canada’s Preparedness for African swine fever with the University of Saskatchewan’s VIDO-InterVac
Extending the lifespan of N95 masks
Canadian universities partner to fight COVID-19 at USask’s VIDO-InterVac
